“Alexion has established itself as a leader in complement biology, bringing life-changing benefits to patients with rare diseases,” AstraZeneca chief executive Pascal Soriot said in a statement, announcing the year’s biggest deal in the pharma sector.
from Hindustan Times - world https://ift.tt/2JXWabL
No comments:
Post a Comment